LGND Stock Analysis: Buy, Sell, or Hold?
LGND - Ligand Pharmaceuticals Inc.
$287.60
8.16 (2.92%)
▲
5d:
+12.67%
30d:
+25.41%
90d:
+42.62%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When LGND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LGND is 11.4% above its trading range ($258.14). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LGND is 11.4% above its trading range ($258.14). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$450.49
Based on 13.4% avg growth
INTRINSIC VALUE TODAY
$279.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LGND is currently trading at $287.60, which is considered extended relative to its 30-day fair value range of $221.34 to $258.14. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.3) compared to its historical average (21.9). At these levels, the market is pricing in 4.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LGND is in a strong uptrend. The price is approaching resistance at $288.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LGND has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LGND is in a strong uptrend. The price is approaching resistance at $288.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LGND has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$221.34 -
$258.14
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
LGND is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($278.89)
- NEUTRAL: PE elevated vs history but 4.8% growth expectation is conservative given 103% recent growth
Trading Range Analysis
30-Day Trading Range
$221.34 -
$258.14
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$245.00
Resistance Level
$288.46
Current Trend
Strong Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.26
Wall Street Target
$278.89
(-0.2%)
Revenue Growth (YoY)
14.1%
Earnings Growth (YoY)
103.2%
Profit Margin
56.0%
Valuation Premium vs History
+4.8% premium
PE vs Historical
25.3 vs 21.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$292.85
(+5%)
2-Year Target
$306.91
(+10%)
3-Year Target
$321.64
(+15%)
3-Yr Target (if PE normalizes)
(PE: 25→22)
PE COMPRESSION
$278.89
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.3, Growth: 22.8%)
$518.00
(+85%)
Base:
(SPY PE: 21.8, Growth: 22.8%)
$446.69
(+60%)
Bear:
(PE: 18.5, Growth: 22.8%)
$379.69
(+36%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 34.14 | Current EPS (TTM): $7.68
Bull Case
$415.46
(+49%)
Analyst growth 44.1%, PE expands to 37.6
Base Case
$377.69
(+35%)
Market implied 44.1%, PE stable at 34.1
Bear Case
$178.28
(-36%)
Severe decline -20.0%, PE contracts to 29.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 24, 2026 2:50 PM ET
Data refreshes hourly during market hours. Next update: 3:50 PM
Data refreshes hourly during market hours. Next update: 3:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGND showing a specific setup today?
Insider Activity (6 Months)
3
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
John W Kozarich
SELL
467 shares
2026-04-01
Andrew Reardon
SELL
5000 shares
2026-04-01
Stephen L Sabba
SELL
1000 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced LGND Option Strategies
Professional options setups generated by AI based on today's LGND price and gamma walls.
